Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sufentanil effect on ciprofol induction dose in elderly patients
ChiCTR2400090926Phase 4Completed
- Sponsor
- The First People's Hospital of Linping District, Hangzhou
- Start
- Oct 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ciprofol and sufentanil in procedural sedation and analgesia (PSA) (2 arms), sponsored by The First People's Hospital of Linping District, Hangzhou. Primary endpoints: Electroencephalographic bispectral index, Ciprofol ED50 and 1 more. Started Oct 2024; status: completed.
02
Drugs
ciprofolsufentanil
03
Conditions
procedural sedation and analgesia (PSA)
Beyond the preview
Go deeper on ChiCTR2400090926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400090926.